A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma Has Undergone Significant Transformation Over Past 12 Months

Share
New Message
Please login to post a reply